Literature DB >> 23331473

Restless legs syndrome induced by quetiapine: report of seven cases and review of the literature.

Hans Rittmannsberger1, Regina Werl.   

Abstract

We report on seven cases of restless legs syndrome (RLS) in patients treated with quetiapine. Small doses (50-250 mg at bedtime) provoked RLS in a dose-dependent way. Most patients suffered from an affective disorder and all were treated concomitantly with antidepressants. A search of the literature revealed a further nine cases of RLS concerning quetiapine, also afflicting only patients with affective disorders. Quetiapine seems to carry a special risk for RLS in this sort of patient. Possible causes for this concurrence are discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23331473     DOI: 10.1017/S1461145712001599

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  5 in total

Review 1.  Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation.

Authors:  Susan Mackie; John W Winkelman
Journal:  CNS Drugs       Date:  2015-05       Impact factor: 5.749

2.  Restless Eating, Restless Legs, and Sleep Related Eating Disorder.

Authors:  Michael J Howell
Journal:  Curr Obes Rep       Date:  2014-03

Review 3.  Gabapentin treatment in clozapine-induced restless legs syndrome: two cases and a review of the literature.

Authors:  Vijaya Kumar; Ganesan Venkatasubramanian
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-12

Review 4.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

Review 5.  Restless Legs Syndrome and the Use of Antipsychotic Medication: An Updated Literature Review.

Authors:  Wael K Saber; Ahad R Almuallim; Rami Algahtani
Journal:  Cureus       Date:  2022-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.